Novel Quinazolinone Derivatives: Synthetic Analogues for the Treatment of Glaucoma, Alzheimers Disease and Diabetes Mellitus
 
Yazarlar (6)
Doç. Dr. Feyzi Sinan TOKALI Kafkas Üniversitesi, Türkiye
Doç. Dr. Parham Taslımı Bartın Üniversitesi, Türkiye
Prof. Dr. Burak Tüzün Sivas Cumhuriyet Üniversitesi, Türkiye
Dr. Öğr. Üyesi Ahmet Karakuş Bartın Üniversitesi, Türkiye
Dr. Öğr. Üyesi Nastaran Sadeghıan Bartın Üniversitesi, Türkiye
Prof. Dr. İlhami Gülçin Atatürk Üniversitesi, Türkiye
Makale Türü Açık Erişim Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Chemistry and Biodiversity (Q3)
Dergi ISSN 1612-1872 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 10-2023
Cilt / Sayı / Sayfa 20 / 10 / – DOI 10.1002/cbdv.202301134
Makale Linki http://dx.doi.org/10.1002/cbdv.202301134
UAK Araştırma Alanları
Organik Kimya Spektroskopi Biyokimya
Özet
Quinazolinones, which represent an important part of nitrogen‐containing six‐membered heterocyclic compounds, are frequently used in drug design due to their wide biological activity properties. Therefore, the novel quinazolinones were synthesized from the reaction of acylated derivatives of 4‐hydroxy benzaldehyde with 3‐amino‐2‐alkylquinazolin‐4(3H)‐ones with good yields (85–94 %) and their structures were characterized using Fourier‐transform Infrared (FT‐IR), Nuclear Magnetic Resonance (1H‐NMR, 13C‐NMR), and High‐Resolution Mass Spectroscopy (HR‐MS). As the application of the synthesized compounds, their inhibition properties of the synthesized compounds on α‐Glucosidase (α‐Glu), Acetylcholinesterase (AChE), Butyrylcholinesterase (BChE), and Carbonic anhydrase I–II (hCA I–II) metabolic enzymes were investigated. All compounds showed inhibition at nanomolar level with the Ki …
Anahtar Kelimeler
ADME/T | cholinesterases | diabetes | molecular docking | quinazolin-4(3H)-one
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Web of Science 41
Scopus 41
Google Scholar 55
Novel Quinazolinone Derivatives: Synthetic Analogues for the Treatment of Glaucoma, Alzheimers Disease and Diabetes Mellitus

Paylaş